Categories


-
  • Affordable Educational Credits
  • Watch At Your Convenience
  • Worldwide Speakers
  • Captivating Topics
  • Peer Interactions

GOLD Learning Speakers

United States

Mary Regan, PhD, RN

  • Speaker Type: The Microbiome in the Perinatal Period
  • Country: United States
Biography:

Mary Regan has a strong clinical background in perinatal nursing, with specific training and expertise in bio informatics. She trained as a certified nurse midwife in the United Kingdom and spent over 19 years working as a perinatal nurse specialist where she gained considerable expertise in pregnancy related health issues. She has been the PI on many State-funded grants and has received NIH funding for a grant focused on women’s decision making about birth (R21 HD059074-01A1) and the vaginal microbiota in preterm birth (R01NR014826-02). The findings from the R21 have been presented internationally and multiple publications have disseminated the findings. The R01 is in its final year and to date over 200 women have been recruited from the birthing population in Baltimore and followed for six month through pregnancy and to the post part period. Dr. Regan works as an Associate Professor in the School of Nursing at the University of Maryland. She serves on the board of Improving Birth.

CE Library Presentation(s) Available Online:
This Presentation is Currently Offline
Birth, Eating and the Microbiota
Emerging research about the role of the gastro intestinal microbiota (GI) and host physiology provides mechanistic understanding that elucidates the relationship between diet and preterm birth (PTB). This presentation evaluates the current evidence about those relationships ( diet, the vaginal and GI microbiota and PTB). The studies that taken together suggest that diet modulates changes in the composition, stability and diversity of the vaginal and GI microbiota, resulting in microbial states that increase the likelihood of PTB. Understanding the critical role that diet, the vaginal and GI microbiota plays in PTB is essential for developing clinical interventions that leverage the capacity of the microbiota to optimize health outcomes.